Imperial College London
London, United Kingdom
Purpose
to continue to develop a rapid, robust and economical test to measure CD4+ T cells in people living with HIV/AIDS in limited-resource settings and which will be used to aid treatment decisions to begin anti-retroviral therapy (ART)
Division
Global Health
Date
November 2008
Region Served
GLOBAL
Committed amount
$7,344,583
Grant topic
HIV
Duration (months)
32
Grantee location
London, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.